A citation-based method for searching scientific literature

Aung Ko Win, Noralane M Lindor, Mark A Jenkins. Breast Cancer Res 2013
Times Cited: 79







List of co-cited articles
643 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
27

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
Aung Ko Win, Joanne P Young, Noralane M Lindor, Katherine M Tucker, Dennis J Ahnen, Graeme P Young, Daniel D Buchanan, Mark Clendenning, Graham G Giles, Ingrid Winship,[...]. J Clin Oncol 2012
207
20


Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
593
20

MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.
Maegan E Roberts, Sarah A Jackson, Lisa R Susswein, Nur Zeinomar, Xinran Ma, Megan L Marshall, Amy R Stettner, Becky Milewski, Zhixiong Xu, Benjamin D Solomon,[...]. Genet Med 2018
70
20

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D Potter, Annika Lindblom, Kristina Lagerstedt, Stephen N Thibodeau, Noralane M Lindor,[...]. Gastroenterology 2008
345
16

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
437
16

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
176
16

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
Aung Ko Win, Noralane M Lindor, Joanne P Young, Finlay A Macrae, Graeme P Young, Elizabeth Williamson, Susan Parry, Jack Goldblatt, Lara Lipton, Ingrid Winship,[...]. J Natl Cancer Inst 2012
133
13

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
13

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
493
13

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
Patrice Watson, Hans F A Vasen, Jukka-Pekka Mecklin, Inge Bernstein, Markku Aarnio, Heikki J Järvinen, Torben Myrhøj, Lone Sunde, Juul T Wijnen, Henry T Lynch. Int J Cancer 2008
371
13

Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
Elaine F Harkness, Emma Barrow, Katy Newton, Kate Green, Tara Clancy, Fiona Lalloo, James Hill, D Gareth Evans. J Med Genet 2015
44
25

Cancer risks for MLH1 and MSH2 mutation carriers.
James G Dowty, Aung K Win, Daniel D Buchanan, Noralane M Lindor, Finlay A Macrae, Mark Clendenning, Yoland C Antill, Stephen N Thibodeau, Graham Casey, Steve Gallinger,[...]. Hum Mutat 2013
151
12

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
389
12

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
327
12

Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Laura Baglietto, Noralane M Lindor, James G Dowty, Darren M White, Anja Wagner, Encarna B Gomez Garcia, Annette H J T Vriends, Nicola R Cartwright, Rebecca A Barnetson, Susan M Farrington,[...]. J Natl Cancer Inst 2010
232
12

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
483
12

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
312
12

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M A Rodriguez-Bigas, C R Boland, S R Hamilton, D E Henson, J R Jass, P M Khan, H Lynch, M Perucho, T Smyrk, L Sobin,[...]. J Natl Cancer Inst 1997
790
11

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
John Burn, Anne-Marie Gerdes, Finlay Macrae, Jukka-Pekka Mecklin, Gabriela Moeslein, Sylviane Olschwang, Diane Eccles, D Gareth Evans, Eamonn R Maher, Lucio Bertario,[...]. Lancet 2011
590
11

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
472
11

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006
473
11

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
Noralane M Lindor, Gloria M Petersen, Donald W Hadley, Anita Y Kinney, Susan Miesfeldt, Karen H Lu, Patrick Lynch, Wylie Burke, Nancy Press. JAMA 2006
419
11

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
427
11

Evidence for breast cancer as an integral part of Lynch syndrome.
Nicole Buerki, Lucienne Gautier, Michal Kovac, Giancarlo Marra, Mauro Buser, Hansjakob Mueller, Karl Heinimann. Genes Chromosomes Cancer 2012
43
20

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
11

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
11

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
11

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
923
10


Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
547
10

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
10

Prediction of germline mutations and cancer risk in the Lynch syndrome.
Sining Chen, Wenyi Wang, Shing Lee, Khedoudja Nafa, Johanna Lee, Kathy Romans, Patrice Watson, Stephen B Gruber, David Euhus, Kenneth W Kinzler,[...]. JAMA 2006
246
10

Mutations in BRIP1 confer high risk of ovarian cancer.
Thorunn Rafnar, Daniel F Gudbjartsson, Patrick Sulem, Aslaug Jonasdottir, Asgeir Sigurdsson, Adalbjorg Jonasdottir, Soren Besenbacher, Pär Lundin, Simon N Stacey, Julius Gudmundsson,[...]. Nat Genet 2011
239
10

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
325
10

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
Sanne W ten Broeke, Richard M Brohet, Carli M Tops, Heleen M van der Klift, Mary E Velthuizen, Inge Bernstein, Gabriel Capellá Munar, Encarna Gomez Garcia, Nicoline Hoogerbrugge, Tom G W Letteboer,[...]. J Clin Oncol 2015
122
10

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
502
10

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Douglas F Easton, Fabienne Lesueur, Brennan Decker, Kyriaki Michailidou, Jun Li, Jamie Allen, Craig Luccarini, Karen A Pooley, Mitul Shah, Manjeet K Bolla,[...]. J Med Genet 2016
71
11

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
Steven Lemery, Patricia Keegan, Richard Pazdur. N Engl J Med 2017
282
10

Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Carin R Espenschied, Holly LaDuca, Shuwei Li, Rachel McFarland, Chia-Ling Gau, Heather Hampel. J Clin Oncol 2017
77
10

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
290
10

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
928
8

Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
289
8

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Uri Ladabaum, Grace Wang, Jonathan Terdiman, Amie Blanco, Miriam Kuppermann, C Richard Boland, James Ford, Elena Elkin, Kathryn A Phillips. Ann Intern Med 2011
239
8

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
657
8

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
582
8

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
320
8

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
776
8

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.